Last reviewed · How we verify
nomegestrol acetate and estradiol — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
nomegestrol acetate and estradiol (nomegestrol acetate and estradiol) — Organon and Co.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| nomegestrol acetate and estradiol TARGET | nomegestrol acetate and estradiol | Organon and Co | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- nomegestrol acetate and estradiol CI watch — RSS
- nomegestrol acetate and estradiol CI watch — Atom
- nomegestrol acetate and estradiol CI watch — JSON
- nomegestrol acetate and estradiol alone — RSS
Cite this brief
Drug Landscape (2026). nomegestrol acetate and estradiol — Competitive Intelligence Brief. https://druglandscape.com/ci/nomegestrol-acetate-and-estradiol. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab